Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Adult Clinical Oral Nutrition Market
Adult Clinical Oral Nutrition Market Size
Adult Clinical Oral Nutrition Market size crossed USD 8 billion in 2022 and is poised to depict over 5% CAGR through 2023-2032, on account of the growing burden of chronic diseases.
With the mounting prevalence of non-communicable diseases such as malnutrition and obesity, the rate of prolonged hospitalization is increasing globally. Based on study data from Baxter International, approximately 2 million hospital stays involve malnutrition in the U.S. Such factors will boost the acceptance of oral nutritional therapy as a safe and effective way to fight adult malnutrition. Likewise, the burden of chronic and metabolic disorders has risen across the globe, further increasing demand for the therapy.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 8 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5% |
| 2032 Value Projection: | USD 13 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 280 |
| Tables, Charts & Figures: | 387 |
| Segments covered: | Product, Therapeutic Area, Form, Sales Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Additionally, according to the International Diabetes Federation, in 2021, over 537 million adults were diagnosed with diabetes in middle- and low-income countries. The requirement for malnutrition management among hospitalized patients with diabetes will therefore surge and in turn, strengthen the industry outlook. However, the introduction of stringent regulatory frameworks associated with product efficacy and labeling may restrict the development of adult oral nutrition support solutions to some extent over the forecast period.
Adult Clinical Oral Nutrition Market Analysis
Adult clinical oral nutrition market value from the milk-based product segment is expected to surpass USD 6.5 billion by 2032, given the high concentration of calcium, potassium, and other nutrients. In addition, milk-based clinical nutrition has emerged as an efficient dietary option for obesity treatment in adult patients. According to the U.S. Dairy Export Council, these dairy proteins consist of several nutrients required to treat cancer and gastrointestinal diseases, in turn contributing to product consumption across the healthcare sector.
Based on the therapeutic area, the adult clinical oral nutrition market size from the malnutrition segment is set to be valued at more than USD 4 billion by 2032. The increasing knowledge about the benefits of varied oral nutrition types in the precise management of nutrient imbalance or impaired nutrient utilization is a major growth driver for the adult clinical oral nutrition industry. Such factors will augment the need for efficient nutritional supplements to boost immunity and consequently, create lucrative opportunities for adult oral clinical nutrition product development.
Adult clinical oral nutrition market from the liquid form segment will be worth over USD 5.5 billion by 2032, due to the growing cases of protein deficiency. Based on estimates from the Annals of the New York Academy of Sciences, almost 1 billion people across the globe have inadequate protein intake. As a result, the consumption of ready-to-drink protein supplements is like to rise. Furthermore, liquid supplements are gaining massive momentum among patients who have undergone major surgeries. The introduction of surgical quality improvement programs in hospitals will therefore boost the intake of liquid nutritional supplements.
The brick-and-mortar sales channel segment accounted for a substantial share of the adult clinical oral nutrition market in 2022, given the better inventory options and no shipping costs, among other benefits. The introduction of pharmacy chain expansion projects has also increased in emerging nations. For example, in January 2023, Reliance Retail unveiled plans to open over 2,000 standalone pharmacy stores within one year. Such initiatives, alongside the delivery of personalized nutrition plans by in-store dietitians, will encourage patients to opt for clinical oral nutrition therapies from brick-and-mortar stores.
Europe adult clinical oral nutrition market share is projected to depict over 4.5% CAGR through 2032, driven by the rising adoption of sedentary lifestyle and the high malnutrition prevalence. As per statistics from Health Europa, almost 1 in 10 older adults aged 65 years or above are malnourished or at risk of malnutrition in the UK. Furthermore, with the escalating number of geriatric patients suffering from intestinal obstruction and other gastrointestinal disorders, the intake of clinical oral nutrition solutions will grow in the region.
Adult Clinical Oral Nutrition Market Share
- Perrigo Company
- Ajinomoto Cambrooke, Inc.
- Victus, Inc. (Megalabs)
- Meiji Holdings, Co. Ltd.
- Danone
- Fresenius Kabi AG
- B Braun Melsungen AG
- Medtrition
- Cantabria Labs
- Usana Health Sciences
- Archer Daniels Midland Company
- Otsuka Pharmaceutical Co., Ltd.
- Herbalife Nutrition
- Nestle Health Science S.A. (Nestle S.A.)
- Abbott Laboratories
are some of the key players in the market. Mergers and acquisitions are among the key strategies being employed by these companies to expand their presence in the global market.
Impact of COVID-19 pandemic
Malnutrition has become an imminent urban challenge and was further intensified by the COVID-19 outbreak. This growing burden of malnutrition is mainly due to the rising food prices and the declining income in the aftermath of the pandemic. In middle- and low-income countries, for example, COVID-19-induced food insecurity has significantly impacted the urban poor population. Factors such as these will boost awareness about the benefits of clinical oral nutrition among adults and subsequently strengthen the industry outlook over the estimated timeline.
Adult clinical oral nutrition market research report includes in-depth coverage of the industry with estimates & forecast in terms of USD Million from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Product
- Milk Based Products
- Fruit Drinks
- Desserts
- Savory Products
- Others
By Therapeutic Area
- Malnutrition
- Dysphagia
- Glycemia
- Cancer
- Gastrointestinal Disorders
- Others
By Form
- Powder
- Liquid
- Others
By Sales Channel
- Brick and mortar stores
- Hospital Pharmacies
- E-commerce
- Others
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Belgium
- Poland
- Switzerland
- Sweden
- Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Columbia
- Peru
- MEA
- South Africa
- Saudi Arabia
- UAE
- Iran
- Egypt
- Israel
Frequently Asked Questions (FAQ) :